Global Cannabis Capsule Market
市场规模(十亿美元)
CAGR : %
Forecast Period |
2023 –2030 |
Market Size (Base Year) |
USD 28.00 Billion |
Market Size (Forecast Year) |
USD 128.54 Billion |
CAGR |
|
Major Markets Players |
|
>全球大麻胶囊市场,按产品(高 THC 胶囊、THC/CBD 平衡胶囊、高 CBD 数字胶囊)、化合物(四氢大麻酚 (THC) 主导、大麻二酚 (CBD) 主导)、应用(医疗、娱乐)、最终用户(医院药房、零售药房、药店、网上销售)划分——行业趋势和预测到 2030 年。
大麻胶囊市场分析及规模
根据调查,加拿大近 13,400 名医生每天为患者开出平均 2.1 克大麻的处方。针对各种治疗领域(尤其是大麻二酚的使用)的大麻药物科学试验数量不断增加,推动了市场增长。截至 2018 年 6 月,已完成或正在进行的临床试验约为 400 项。GW Pharmaceuticals 赞助的临床试验为 40 项,而赛诺菲赞助的临床试验为 38 项。此外,医生对大麻益处的描述以及支持性临床证据导致患者开出的大麻药物处方数量增加。
Data Bridge Market Research 分析称,2022 年全球大麻胶囊市场价值为 280 亿美元,预计到 2030 年将达到 1285.4 亿美元,预测期内复合年增长率为 18.7%。由于人们对微整美容手术的需求很高,“紧肤”是相应市场中最大的应用领域。除了对市场价值、增长率、细分、地理覆盖范围和主要参与者等市场情景的洞察外,Data Bridge Market Research 整理的市场报告还包括深入的专家分析、患者流行病学、渠道分析、定价分析和监管框架。
报告范围和市场细分
报告指标 |
细节 |
预测期 |
2023 至 2030 年 |
基准年 |
2022 |
历史岁月 |
2021 (可定制为 2015-2020) |
定量单位 |
收入(十亿美元),定价(美元) |
涵盖的领域 |
产品(高 THC 胶囊、THC/CBD 平衡胶囊、高 CBD 数字胶囊)、化合物(四氢大麻酚 (THC) 主导、大麻二酚 (CBD) 主导)、应用(医疗、娱乐)、最终用户(医院药房、零售药房、药店、在线销售)。 |
覆盖国家 |
美国、加拿大和墨西哥、德国、法国、英国、荷兰、瑞士、比利时、俄罗斯、意大利、西班牙、土耳其、欧洲其他地区、中国、日本、印度、韩国、新加坡、马来西亚、澳大利亚、泰国、印度尼西亚、菲律宾、亚太其他地区、沙特阿拉伯、阿联酋、南非、埃及、以色列、中东和非洲其他地区、巴西、阿根廷和南美洲其他地区。 |
涵盖的市场参与者 |
Joy Organics (U.S.), CBD istillery (U.S.), Gaia Botanicals (U.S.), Harmony (U.S.), Floyd’s of Leadville (U.S), Lazarus Naturals (U.S.), cbd MD (U.S.), Pure Hemp Botanicals (U.S.), ENDOCA (Netherlands), Green Roads (U.S.), Tilray (U.S.), Canopy Growth Corp. (Canada), GW Pharmaceuticals PLC (U.K.), Aurora Cannabis (Canada), Aphria Inc. (Canada), CV sciences Inc. (U.S.) |
Market Opportunities |
|
Market Definition
Cannabis, sometimes known as marijuana, is a psychoactive substance that is used for both medical and recreational purposes. Cannabis has a long list of health benefits, including relief from restlessness, muscle contractions, and chronic discomfort, as well as a reduction in vomiting and illness caused by chemotherapy.
Global Cannabis Capsule Market Dynamics
Drivers
- Advancements in research and development
Cannabis is now approved for the treatment of a variety of ailments, including restlessness, muscle tightness, persistent discomfort, and the reduction of vomiting and illness caused by chemotherapy. The majority of businesses are making rapid progress in their research into the potential of therapeutic cannabis and hemp.
- Cannabinol and tetrahydrocannabinol-modified edibles
CBD and THC-modified edibles are becoming increasingly popular throughout all permitted states. In addition, customers and investors are becoming more interested in infused drinks. The convoluted administrative process for cannabis acceptance can act as a roadblock to industry development. The therapeutic properties of cannabis, as well as the ongoing legalisation of cannabis capsules, will serve as opportunities for market expansion.
- Increasing legalization of cannabis
Medicinal cannabis accounts for a significant component of the cannabis industry. Australia, Canada, Chile, Colombia, Germany, Greece, Israel, Italy, the Netherlands, Peru, Poland, Portugal, Goa, and Uruguay are among the countries that have allowed the use of cannabis for therapeutic purposes. Consumers in cannabis-legalized states in the United States are often over the age of 50. This demographic profile is predicted to raise cannabis demand in the country due to a higher likelihood of chronic diseases after 50 years of age and the effectiveness of cannabis in treating such conditions. Symptoms and conditions that can be treated by cannabis, according to the US Government Accountability Office (under State Medical Marijuana Laws), include anorexia, HIV-AIDS, glaucoma, cancer, arthritis, epilepsy, nausea, pain, cachexia, Crohn's disease, Alzheimer's disease, migraines, multiple sclerosis, spasticity, and wasting syndrome. Cannabis' popularity and demand are projected to rise in the future as a result of ongoing research and the standardization of products for medicinal uses.
Opportunities
- Intended medicinal benefits
To provide the intended medicinal benefits, capsule doses must be precise before consumption. More dependable is the use of advanced technology, a qualified, licensed lab technician, and a producer. Because medical cannabis is now legal in the U.S., demand for it is growing at a rapid pace, owing to the medicinal benefits that cannabis capsules provide. As a result, investors are keen on establishing or acquiring plants with the necessary gear, skilled labor, and a license to create cannabis capsules. Existing manufacturers are also devoting time and resources to developing new methods for producing high-quality capsules in appropriate doses.
Restraints/Challenges
- High cannabis pill dosages
As a result, cannabis capsules are being made in order to make precise and calculated dosages of a variety of different medications, including cannabis. These calculated cannabis pill dosages are in high demand around the world, as they will open up a slew of new medical procedures to treat patients with Alzheimer's illness, glaucoma, PTSD, muscular spasms, and other ailments. Cannabis can be injected into the patient's body in a variety of ways, but the most efficient and dependable method is still the oral route because it is the most simple and convenient for the patient. THC capsules, for example, are taken orally and take 45 minutes to 3 hours to take effect. Because cannabis capsules are absorbed through the digestive system and digested by the body, the effect is very efficient.
This cannabis capsule market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the cannabis capsule market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.
Recent Development
- In March 2021 - STADA Arzneimittel AG, a leading German pharmaceutical company, has entered the medical cannabis market with an agreement with MediPharm Labs, a Canadian startup, to launch two flower products and perhaps six more
- In May 2021- TCV Sciences, Inc. announced the launch of PLUSCBDTM calm and sleep gummies, two tasty candies that help individuals go back to their normal routines by supporting healthy stress responses and sleep cycles
Global Cannabis Capsule Market Scope
The cannabis capsule market is segmented on the basis of product type, compound, application and end-user. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.
Product Type
- High THC Capsule
- THC/CBD Balanced Capsules
- High CBD Capsules Digital
Compound
- Tetrahydrocannabinol (THC)-Dominant
- Cannabidiol (CBD)-Dominant
Application
- Medical
- Recreational
End User
- Hospital Pharmacies
- Retail Pharmacies
- Drug Stores
- Online Sales
Global Cannabis Capsule Market Regional Analysis/Insights
The cannabis capsule market is analyzed and market size insights and trends are provided by country, product type, compound, application and end-user as referenced above.
The countries covered in the cannabis capsule market report are U.S., Canada, Mexico, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, rest of Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, rest of Asia-Pacific, Saudi Arabia, U.A.E, South Africa, Egypt, Israel, rest of Middle East and Africa, Brazil, Argentina and rest of South America.
North America is expected to be the dominant and fastest growing region due to the expansion of the major players' production capacities.
报告的国家部分还提供了影响单个市场因素和国内市场监管变化,这些因素和变化会影响市场的当前和未来趋势。下游和上游价值链分析、技术趋势和波特五力分析、案例研究等数据点是用于预测单个国家市场情景的一些指标。此外,在提供国家数据的预测分析时,还考虑了全球品牌的存在和可用性以及它们因来自本地和国内品牌的激烈或稀缺竞争而面临的挑战、国内关税和贸易路线的影响。
竞争格局和全球大麻胶囊市场份额分析
大麻胶囊市场竞争格局按竞争对手提供详细信息。详细信息包括公司概况、公司财务状况、产生的收入、市场潜力、研发投资、新市场计划、全球影响力、生产基地和设施、生产能力、公司优势和劣势、产品发布、产品宽度和广度、应用主导地位。以上提供的数据点仅与公司对大麻胶囊市场的关注有关。
大麻胶囊市场的一些主要参与者包括:
- Joy Organics(美国)
- CBD 酿酒厂(美国)
- Gaia Botanicals(美国)
- Harmony(美国)
- 莱德维尔的弗洛伊德 (美国)
- Lazarus Naturals(美国)
- cbd MD(美国)
- 纯大麻植物药(美国)
- ENDOCA(荷兰)
- 绿色道路(美国)
- Tilray(美国)
- Canopy Growth Corp.(加拿大)
- GW Pharmaceuticals PLC(英国)
- Aurora Cannabis(加拿大)
- Aphria Inc.(加拿大)
- CV Sciences Inc.(美国)
SKU-
Get online access to the report on the World's First Market Intelligence Cloud
- Interactive Data Analysis Dashboard
- Company Analysis Dashboard for high growth potential opportunities
- Research Analyst Access for customization & queries
- Competitor Analysis with Interactive dashboard
- Latest News, Updates & Trend analysis
- Harness the Power of Benchmark Analysis for Comprehensive Competitor Tracking
研究方法
Data collection and base year analysis are done using data collection modules with large sample sizes. The stage includes obtaining market information or related data through various sources and strategies. It includes examining and planning all the data acquired from the past in advance. It likewise envelops the examination of information inconsistencies seen across different information sources. The market data is analysed and estimated using market statistical and coherent models. Also, market share analysis and key trend analysis are the major success factors in the market report. To know more, please request an analyst call or drop down your inquiry.
The key research methodology used by DBMR research team is data triangulation which involves data mining, analysis of the impact of data variables on the market and primary (industry expert) validation. Data models include Vendor Positioning Grid, Market Time Line Analysis, Market Overview and Guide, Company Positioning Grid, Patent Analysis, Pricing Analysis, Company Market Share Analysis, Standards of Measurement, Global versus Regional and Vendor Share Analysis. To know more about the research methodology, drop in an inquiry to speak to our industry experts.
可定制
Data Bridge Market Research is a leader in advanced formative research. We take pride in servicing our existing and new customers with data and analysis that match and suits their goal. The report can be customized to include price trend analysis of target brands understanding the market for additional countries (ask for the list of countries), clinical trial results data, literature review, refurbished market and product base analysis. Market analysis of target competitors can be analyzed from technology-based analysis to market portfolio strategies. We can add as many competitors that you require data about in the format and data style you are looking for. Our team of analysts can also provide you data in crude raw excel files pivot tables (Fact book) or can assist you in creating presentations from the data sets available in the report.